Back to search results

Gluten Technology and Education for Celiac Health Study

This study is looking at new ways to help adults recently diagnosed with celiac disease manage their condition. It will test if using portable technology to detect gluten after eating, combined with regular online meetings with a dietitian (telemedicine monitoring), can help your small intestine heal better. The main goal is to see how well your small intestine heals after 12 months. You might be able to join if you are between 18 and 75 years old, have a confirmed celiac disease diagnosis within the last four months, and are willing to use the gluten-detection technology. The study is currently unclear on its recruitment status.

Study design
This is a multi-center randomized controlled trial planning to enroll 200 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your small intestinal healing will be measured at 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06059716

Gluten Technology and Education for Celiac Health

Recruiting
NAAges 18–75InterventionalTreatment
Columbia University
~200 participants
Updated 2026-06-10 on ClinicalTrials.gov
What's tested:Gluten detection technologyContinuous telemedicine monitoring

At a glance

Recruiting sites
4 of 4 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Small Intestinal Healing
Measured over 12 months

Conditions

Celiac Disease

Explore related trials

Celiac Disease

NCT06059716

Where you'd take part

This study runs at 4 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • University of Chicago Medical Center

    Chicago, Illinoisstudy coordinator listed

    Recruiting

  • Vanderbilt University Medical Center

    Nashville, Tennesseestudy coordinator listed

    Recruiting

  • Beth Israel Deaconess Medical Center

    Boston, Massachusettsno site contact published

    Recruiting

  • Columbia University Irving Medical Center

    New York, New Yorkno site contact published

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Benjamin Lebwohl, MD, MS · PRINCIPAL_INVESTIGATOR · Columbia University

Who to contact

Benjamin Lebwohl, MD, MS
[email protected]
212-305-9338
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Any gender; Age 18-75 years
Celiac disease diagnosis by serology and duodenal biopsy (corresponding to •Marsh 3 histology), adequate sampling and interpretable villus height to crypt depth ratio upon review by our study pathologist
Diagnosed with celiac disease within 4 months of initial study screening
Willingness to use gluten-detection technology
Not currently using a gluten detection technology that tests for gluten in urine or stool

Exclusion

Currently pregnant or planning to become pregnant during the study
Not planning to follow a gluten-free diet
Concurrent participation in a clinical trial of an experimental pharmacologic agent (for any condition).

What this trial measures

  • Small Intestinal Healing12 months

    This will be measured with a measure in villus height to crypt depth ratio on small intestinal biopsy.